6039 — Japan Animal Referral Medical Center Co Income Statement
0.000.00%
- ¥15bn
- ¥18bn
- ¥5bn
- 91
- 27
- 97
- 86
Annual income statement for Japan Animal Referral Medical Center Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,848 | 2,979 | 3,873 | 4,270 | 5,278 |
| Cost of Revenue | |||||
| Gross Profit | 995 | 1,105 | 1,443 | 1,464 | 1,833 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,448 | 2,556 | 3,314 | 3,793 | 4,559 |
| Operating Profit | 400 | 423 | 558 | 478 | 719 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 412 | 424 | 534 | 491 | 720 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 285 | 287 | 381 | 337 | 521 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 285 | 287 | 381 | 337 | 521 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 285 | 287 | 381 | 337 | 521 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 118 | 122 | 166 | 133 | 209 |
| Dividends per Share |